Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

GP KFPs / SAQswomens-health

GP KFPs / SAQs · womens-health

Breast symptoms in general practice — KFP-style written assessment

KFP-style staged scenarios on breast symptoms: the triple assessment pathway, mastalgia management with evidence, nipple discharge sorting, breast abscess drainage, and the reassurance consultation.

30 marks45 min3 min readVerification in progress

Target exams

RACGP KFPRACGP AKTMRCGP AKT
On this page
Study tools

Target exams

RACGP KFPRACGP AKTMRCGP AKT
Prompt
Breast symptoms: examine, sort, refer — the triple assessment pathway and the benign majority

KFP 1 (10 marks)

A 29-year-old woman presents with a three-month history of right-sided breast pain, worse before her period, bilateral but worse on the right. Examination reveals generalised nodularity, no discrete lump, no skin or nipple change, no axillary nodes. She is terrified she has cancer — her aunt died of it at 55. [5] [10]

  1. What is the likely diagnosis and what is her cancer risk with pain alone? (3) [5]
  2. Outline your evidence-based management ladder. (4) [10] [4]
  3. She asks whether evening primrose oil would help. What does the evidence say? (3) [10]

Model answers

  1. Cyclical mastalgia (worse premenstrually, bilateral, hormonal pattern). Cancer risk with pain as the only symptom is low — 1.24% in a series of 447 women, and all four cancers had an abnormality on clinical examination. Her family history raises her baseline risk and justifies formal risk assessment, but the pain itself is not the cancer presentation. [5]
  2. Ladder: (1) reassurance after proper examination — the majority need nothing more once cancer is excluded; (2) well-fitting supportive bra plus topical NSAID gel massage — usually effective as a combination; (3) second-line for severe refractory cyclical pain: anti-oestrogen therapy (tamoxifen or centchroman) for 3–6 months — topical 4-hydroxytamoxifen gel reduced pain significantly versus placebo (−12.71 mm VAS) with excellent tolerability; (4) danazol for resistant cases. Set expectations: cyclical pain resolves spontaneously in 20–30% but recurs in 60%. [10] [4]
  3. It does not work. Systematic review evidence states gamma-linolenic acid/evening primrose oil, though commonly prescribed, is not effective for mastalgia. Chamomile extract showed benefit over placebo for mild-to-moderate cyclical mastalgia in a double-blind RCT if she wants a low-risk adjunct. [10] [12]
General Practice Pro

Continue reading

You have read the opening of this kfps / saq. The complete unit — every section and its primary-source references — is part of the General Practice fellowship library.

Sign in to continueSee pricing
References28ShowHide
  1. [1]Khawaja AR, Allan SM Has the breast cancer 'two week wait' guarantee for assessment made any difference? Eur J Surg Oncol, 2000.PMID 11034802
  2. [2]Clarke D, Sudhakaran N, Gateley CA Replace fine needle aspiration cytology with automated core biopsy in the triple assessment of breast cancer Ann R Coll Surg Engl, 2001.PMID 11320918
  3. [3]Meechan GT, et al. Who is not reassured following benign diagnosis of breast symptoms? Psychooncology, 2005.PMID 15386770
  4. [4]Mansel R, et al. A phase II trial of Afimoxifene (4-hydroxytamoxifen gel) for cyclical mastalgia in premenopausal women Breast Cancer Res Treat, 2007.PMID 17351746
  5. [5]Clegg-Lamptey JN, et al. Breast cancer risk in patients with breast pain in Accra, Ghana East Afr Med J, 2007.PMID 17892195
  6. [6]Ghimire B, et al. Accuracy of triple test score in the diagnosis of palpable breast lump JNMA J Nepal Med Assoc, 2008.PMID 19079392
  7. [7]Donnelly J Breast lump detection: who is more accurate, patients or their GPs? Int J Clin Pract, 2010.PMID 20015214
  8. [8]Goyal A Breast pain BMJ Clin Evid, 2011.PMID 21477394
  9. [9]Jan M, et al. Triple assessment in the diagnosis of breast cancer in Kashmir Indian J Surg, 2010.PMID 23133217
  10. [10]Kataria K, et al. A systematic review of current understanding and management of mastalgia Indian J Surg, 2014.PMID 25177120
  11. [11]Nakhlis F, et al. Papilloma on core biopsy: excision vs. observation Ann Surg Oncol, 2015.PMID 25361885
  12. [12]Saghafi N, et al. Effectiveness of Matricaria chamomilla (chamomile) extract on pain control of cyclic mastalgia: a double-blind randomised controlled trial J Obstet Gynaecol, 2018.PMID 29072514
  13. [13]Mišković J, et al. Diagnostic Value of Fine Needle Aspiration Cytology for Breast Tumors Acta Clin Croat, 2016.PMID 29117654
  14. [14]Zhou Y, et al. Variation in 'fast-track' referrals for suspected cancer by patient characteristic and cancer diagnosis: evidence from 670 000 patients with cancers of 35 different sites Br J Cancer, 2018.PMID 29182609
  15. [15]Mazari FAK, et al. The need for triple assessment and predictors for diagnosis of breast cancer in patients <40 years of age Clin Radiol, 2018.PMID 29731127
  16. [16]Quinlan A, et al. Quantifying patient preferences for symptomatic breast clinic referral: a decision analysis study BMJ Open, 2018.PMID 29858402
  17. [17]Barakzai N, Mansoor E, Buccimazza I Is conservative management of fibroadenomas feasible? 5-year results from the Durban Breast Unit S Afr J Surg, 2021.PMID 34212569
  18. [18]Rai A, et al. Study of Diagnostic Delay among Symptomatic Breast Cancer Patients in Northern India: A Mixed-Methods Analysis from a Dedicated Breast Cancer Centre Asian Pac J Cancer Prev, 2022.PMID 35345361
  19. [19]Zhang M, et al. Imaging and Management of Fibroepithelial Lesions of the Breast: Radiologic-Pathologic Correlation Radiographics, 2023.PMID 37856317
  20. [20]Gil Quessep E, et al. Subgroups varying in risk and density highlight the potential for stratified breast cancer screening Eur J Cancer, 2025.PMID 39805236
  21. [21]More RS, Dumbre S, Dikle AM Efficacy of Modified Triple Assessment in Diagnosing Breast Lesions: A Prospective Observational Study Cureus, 2025.PMID 40314043
  22. [22]Ahire P, et al. Unraveling Benign Breast Conditions: A Comprehensive Study of Diagnosis, Treatment, and Care Cureus, 2025.PMID 40600088
  23. [23]Jansen C, et al. Surgical treatment of breast fibroadenomas Dan Med J, 2025.PMID 41069312
  24. [24]Moshina N, et al. Breast cancer mortality among women who have attended BreastScreen Norway, 1996-2023 Breast Cancer Res, 2026.PMID 41845512
  25. [25]Pestrin O, et al. A longitudinal observational study of male referrals and adherence to imaging guidelines: a single centre experience in 148 patients Front Oncol, 2026.PMID 42022318
  26. [26]Scardina L, et al. Management of lactational and non-lactational breast abscesses: an evidence-based framework to support breast surgeon decision-making Updates Surg, 2026.PMID 42334816
  27. [27]Zhong W, et al. Clinical factors of prolonged treatment duration in patients with non-puerperal mastitis Gland Surg, 2026.PMID 42445087
  28. [28]Boldrini C, et al. The Gems and Pitfalls of Inflammatory Breast Disease: An Illustrated Review of Mastitis. What the Radiologist Should Know Radiol Res Pract, 2026.PMID 42540206
General Practice Pro

$29/ monthor $279 / year

The complete General Practice library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousAbnormal uterine bleeding — KFP-style written assessmentwomens-healthNextCervical screening (HPV-based program) — KFP-style written assessmentwomens-health